Summary In a large cohort of older women, we investigated the relationships that different forms of vitamin E may have with bone turnover markers and bone mineral density (BMD). We found a suggestive positive association between serum alpha-tocopherol and BMD at the femoral neck, but no other clinically relevant observations. Introduction Vitamin E has anti-oxidant and antiinflammatory properties hypothesized to benefit bone, but limited studies exist regarding its homologues. We examined circulating and dietary α-and γ-tocopherols with bone turnover markers (BTMs) and bone mineral density (BMD), and the role of inflammation in this relationship. Methods We performed two cross-sectional analyses from two visits (V2, 1997-1999, n = 3883; V3, 2007-2011, n = 2130) of the Aberdeen Prospective Osteoporosis Screening Study. Dietary and supplement intakes by food frequency questionnaire were assessed at both visits. V2 BTMs (urinary free pyridinoline and deoxypyridinoline, serum Nterminal propeptide of type 1 collagen) and V3 serum α-and γ-tocopherols, inflammatory markers (interleukin-6 [IL-6], serum amyloid A [SAA], high-sensitivity C-reactive protein [hs-CRP], E-selectin) and dual X-ray absorptiometry BMD at the femoral neck and lumbar spine were collected. Food sources of tocopherol homologues and diet-serum correlations were determined. The relationships between dietary tocopherols and BTMs (V2), and dietary and serum tocopherols with BMD (V3) were examined by multivariable regression (adjusting for age, cholesterol, inflammatory markers, carotenoids, body mass index, physical activity level, alcohol intake, smoking status and national deprivation category). Results Serum γ-tocopherol was associated with increasing concentrations of hs-CRP, SAA and E-selectin (P-trend all <0.0001), while α-tocopherol was associated with decreasing concentrations of IL-6 and hs-CRP (P-trend all <0.001). Controlling for covariates, serum α-tocopherol was positively associated with BMD at the femoral neck (β = 0.002, P = 0. 0 4 ) a m o n g t h os e n o t r ep o r t i ng vi t a m i n E supplementation. Conclusion We did not find biologically meaningful results between dietary and tocopherol homologues with BTMs or BMD.
Introduction
Osteoporosis is a personal and economic burden that disproportionately affects post-menopausal women [1] . The rapid decline in circulating oestrogen that occurs with menopause increases production of pro-inflammatory cytokines and oxidative stress, which is linked with bone loss through stimulating bone resorption [2] .
Dietary antioxidants are known for their ability to prevent and reduce oxidative stress, and vitamin E is a potent antioxidant [3] . Interest in vitamin E has mainly focused on α-tocopherol due to its antioxidant function, ability to reverse vitamin E deficiency symptoms in humans and its predominant form in the body [3] . Observational studies have found that individuals with lower intakes of dietary vitamin E intake had increased risk of hip fracture [4, 5] , and osteoporotic, postmenopausal women had lower plasma levels of vitamin E [6, 7] . Animal models of nicotine exposure, when given α-tocopherol, had increased bone formation, reversal of bone loss [8] and decreased circulating concentrations of inflammatory cytokines [9] . Dose may be critical, as high concentrations of α-tocopherol in cell media did not support viability of osteoblasts [10] and have been shown to be pro-oxidants [11] .
However, vitamin E exists in forms: There are eight naturally occurring tocopherol (α, β, δ, γ) and tocotrienol (α, β, δ, γ) homologues [3] . They are found in cereal grains, nuts, seeds and foods that have been fortified with vitamin E; the richest source of tocopherols is found vegetable oils [3, 12] . The extensive use of corn and soybean oils in Westernized countries such as the USA has resulted in γ-tocopherol as the major form of vitamin E intake, although vitamin E supplements largely contain only α-tocopherol [12] .
Although γ-tocopherol is a major form of vitamin E in the diet, there are a limited number of studies on the relationship between γ-tocopherol and bone health. Wolf et al. (2005) examined dietary and serum α-and γ-tocopherols with bone mineral density (BMD) in the Women's Health Initiative (WHI) and found no associations [13] . However, a study using the National Nutrition and Health and Nutrition Examination Survey (NHANES) observed a positive relationship between serum γ-tocopherol with the serum bone formation marker bone-specific alkaline phosphatase (BAP), but not with a biomarker of bone resorption [14] .
γ-tocopherol exhibits different antioxidant activity compared to α-tocopherol, trapping lipophilic electrophiles such as reactive nitrogen oxide species (RNOS) more effectively [3] . Unregulated RNOS production is associated with inflammation-related diseases such as cancer and cardiovascular disease [15] . Reduction of oxidative stress is thought to be a mechanism by which vitamin E homologues protect bone, but human studies have not assessed this relationship. Furthermore, it has been reported that α-and γ-tocopherol have opposing inflammatory functions and may uncouple bone turnover, such as by increasing bone resorption without affecting bone formation [14, 16, 17] .
The main aim of this study was to evaluate the relationships, at two time points, of dietary and serum α-and γ-tocopherols with bone mineral density (BMD) and bone formation and resorption markers. We also examined the relationship between tocopherol homologues and inflammatory markers and smoking and body mass index (BMI), two factors known to affect the inflammatory state [5, [18] [19] [20] , hypothesizing that α-and γ-tocopherol would have opposing associations with BMD and the inflammatory states and markers.
Methods

Study design
Subjects are women from the second and third follow-up visits of Aberdeen Prospective Osteoporosis Screening Study (APOSS) cohort, which initially recruited 5119 women aged 45-54 years between 1990 and 1994 using random selection from Community Health Index records [21] . No exclusion criteria were applied as baseline participants were recruited for a population-based screening programme for osteoporosis fracture risk. Subjects were given questionnaires to evaluate risk factor assessment, dietary intake via food frequency questionnaires (FFQs) and completed bone densitometry scans. Women returned for a follow-up screening (visit 2; n = 3883; 64 % returners from baseline) between 1997 and 1999 and completed a second FFQ and provided non-fasted blood, and second morning fasted urine, samples for analyses of bone markers. In 2007-2011 (visit 3; n = 2130; 66 % returners from visit 2, 42 % returners from baseline), women returned for bone scans, completed a third FFQ and had fasted blood samples collected for lipid, inflammatory markers and tocopherol measurements.
Bone mineral density measurements BMD was measured using dual-energy X-ray absorptiometry (DXA; Lunar iDXA, GE Healthcare, Madison, WI, USA) at the L1-L4 lumbar spine (LS) and femoral neck (FN) at the third visit. Daily encapsulated spine phantom measures were taken, and a plot of phantom measurements showed an upwards shift of 0.7 %; BMDs measured after the phantom shift (n = 193) were adjusted for this shift.
Biochemical measurements
At the second visit, non-fasted blood samples were collected by researchers and participants brought in samples of second early morning fasted urine. At the third visit, fasted (12 h overnight, or 4 h if the participant had an afternoon study visit) blood samples were collected; serum was stored (−80°C for samples from the third visit, −20°C for second visit) prior to analyses.
Serum α-and γ-tocopherol and carotenoids (α-carotene, β-carotene, lycopene, β-cryptoxanthin, lutein/zeaxanthin) concentrations were determined by reversed-phase high-performance liquid chromatography (HPLC) using fluorescence and visible detection after isohexane and chloroform extraction, a modification of a method developed in a 1997 study commissioned by the Ministry for Agriculture Fisheries and Food [22] . Lipids and high-sensitivity C-reactive protein (hs-CRP) were analysed at Aberdeen Royal Infirmary, Aberdeen, UK. Tocopherols, interleukin-6 (IL-6), serum amyloid A (SAA) and E-selectin were analysed at the Rowett Institute of Nutrition and Health, University of Aberdeen, UK. Analyses were conducted under the round-robin scheme "Micronutrients Measurement Quality Assurance Programme" by the National Institute of Standards.
Total cholesterol and high-sensitivity C-reactive protein (hs-CRP) were analysed by an automated assay (ADVIA 2400 Chemistry System; Siemens). Interleukin-6 (IL-6), serum amyloid A (SAA), and E-selectin concentrations were calculated using quantitative sandwich enzyme immunoassay kits (R&D systems). Lipid and inflammatory marker assays showed inter-and intra-assay CV values fewer than 5 %.
Bone formation marker serum N-terminal propeptide of type 1 collagen (P1NP) was measured in non-fasted samples using an enzyme chemiluminescent assay from Roche products. This assay has an inter-and intra-assay coefficient of variation of <4 % across the range 5-100 μg/L, and a sensitivity of 2 μg/L. Bone resorption markers free pyridinoline (fPYD) and free deoxypyridinoline (fDPD) were measured in second early morning fasted urine by reverse-phase HPLC with fluorescence detection. The results were expressed in relation to creatinine (nmol/mmol), which was measured in urine using standard techniques (Roche, Lewes, UK). The inter-assay coefficient of variation for both bone marker methods was 5.5 %.
Assessment of diet, physical activity and covariates
At both visits, participants were weighed in kilograms (kg) on calibrated balance scales (Seca, Hamburg, Germany) while wearing light clothing and no shoes. Heights were measured in centimetres using a stadiometer (Holtain Ltd., Crymych, UK). Body mass index (BMI) was calculated as weight in kilograms divided by height in metres squared.
Dietary intake was assessed using a semi-quantitative 136-question FFQ, validated using 7-day weighed food records [23] . Intakes were calculated using the US Department of Agriculture's food composition database (SR27) as the UK composition of foods database had disproportionate missing data for vitamin E homologues.
Physical activity level (PAL) was obtained using the same questionnaire as the one used in the Scottish Heart Healthy Study [24] . PAL is calculated from the duration and intensity of activity performed in a 24-h period divided by basal metabolic rate; these were assessed for working and non-working days [25] . National deprivation category was assigned from postal codes in 1997-2000; it is calculated by combining variables taken from small-area census data (unemployment, overcrowding, social class, lack of motorized vehicle) where the lowest number denotes the most affluent/least deprived and is used as a measure for socioeconomic status [26] . Questionnaires were used to assess age, menopause status (pre-, peri-, post-menopausal), hormone replacement therapy (HRT; past user, present user) use, smoking status (yes/no) and vitamin E supplement use. Non-responders for supplement use were categorized as non-users while non-response for other questionnaire-derived variables was designated as missing. Participants were asked whether they were currently taking any vitamin, mineral or food supplements (yes/no). If participants checked 'yes', there was available space to provide the details (type, brand name, strength, frequency of intake). Sufficient details were provided by 48 participants at visit 2, and 10 participants at visit 3 to calculate intake.
Statistical analyses
Analyses were carried out using SAS version 9.3 (SAS Institute Inc., Cary, NC, USA). Descriptive statistics were determined, and non-normally distributed variables were natural logarithm transformed prior to analysis. Dietary tocopherols were energy-adjusted using the residual method [27] . Principal components analysis (PCA) was used to derive factors for the five serum carotenoids (r = 0.58-0.86) and the four inflammatory markers(r = 0.15-0.43) to eliminate collinearity. Factor scores were considered with respect to the scree plot, eigenvalue >1 and interpretability of the factors. For serum carotenoids, we retained one factor explaining 74 % of the total variation which our group had previously derived [28] . Three factors for serum inflammatory markers explaining 86 % of the total variation were retained (Online Resource  Table S1 ).
Food group sources of α-and γ-tocopherols were assessed from FFQ data for each visit. Spearman's correlation was used to assess the relationship between dietary intakes of tocopherols with serum concentrations at visit 3.
Linear trend of inflammatory biomarkers, BMI, BMD and covariates across quartiles of serum α-and γ-tocopherol was assessed by orthogonal contrasts using log-transformed variables. Chi-square and Fisher's exact tests were used to assess smoking, vitamin E supplementation and national deprivation categories across serum tocopherol quartiles.
Multivariable linear regression was used to assess the relationship between dietary tocopherol intake at visit 2 with bone formation and resorption markers; at visit 3, LS and FN BMDs were regressed on dietary α-and γ-tocopherols, and serum α-and γ-tocopherols and α/γ ratio. The final models for dietary intakes of tocopherols at both visits controlled for age, BMI, current smoking status (yes, no), alcohol intake and national deprivation category (category 6 [least affluent/most deprived] as reference); visit 2 had the addition of a variable created for a combination of menopause status and HRT use (pre-menopausal, peri-menopausal, post-menopausal never used HRT, post-menopausal past HRT use, post-menopausal present HRT use [reference category]). Serum tocopherol concentrations at visit 3 were controlled for the same variables listed previously and for total cholesterol because the tocopherols are transported via circulation through lipoproteins [29] . Adjusting for serum triglycerides instead of serum cholesterol was similar; therefore, serum cholesterol was used. Additional adjustments for HRT and serum 25-hydroxyvitamin D and parathyroid hormone concentrations did not change conclusions and were not included in final models. Complete case analysis was used for all analyses. One participant at the third visit was excluded from analyses due to being on parenteral nutrition during the period of dietary intake recall. Sensitivity analysis at visit 2 with removal of participants taking bisphosphonates (n = 22) and with bone diseases-rheumatoid arthritis (n = 77), osteoarthritis (n = 597) or other bone diseases (n = 32)-did not change our conclusion so results for all participants are shown. Sensitivity analysis at visit 3 without participants taking vitamin E supplements found differences for some models and are presented.
Results
Our study population at visit 2 had a mean age of 55 (SD 2.2) and 66 (SD 2.2) at the third visit (Table 1) . Smoking decreased from 19.8 to 8.9 % between visits. Mean dietary intakes of α-tocopherol were 8.2 mg/day (SD 1.5) at visit 2 and 7.4 mg/day (SD 1.4) at visit 3 while intakes of γ-tocopherol were 6.8 mg/ day (SD 1.6) and 6.1 mg/day (SD 1.7), respectively.
The eight largest sources of tocopherols in the diet are shown in Online Resource S2. Food sources of α-and γ-tocopherol at both visits were similar, with α-tocopherol intakes coming mostly from fats and oils, vegetables, cereals, and biscuits, cakes, puddings and sweets while γ-tocopherol was mostly obtained from biscuits, cakes, puddings, and sweets, fats and oils, and sauces and condiments. Dietary intake of tocopherols were not correlated with serum concentrations (Online Resource 3).
Increasing quartiles of serum γ-tocopherol were associated with increasing FN BMD, BMI and the inflammatory markers hs-CRP, SAA and E-selectin (P-trend for all <0.0001; Online Resource Table S4 ), and vitamin E supplement users had lower serum γ-tocopherol concentrations compared to participants who did not report vitamin E supplement use. Conversely, increasing quartiles of α-tocopherol were associated with decreasing IL-6, hs-CRP and BMI (P-trend for all <0.0001), fewer smokers (p = 0.006), and vitamin E supplement users had higher average serum concentrations compared to participants who did not report vitamin E supplement use.
In multivariable models, dietary intakes of α-and γ-tocopherol at visit 2 were not associated with any bone turnover markers when controlling for covariates (Table 2) . At visit 3, dietary intake of α-tocopherol was marginally associated with FN BMD (β = 0.002, P = 0.04); no other dietary associations were observed (Table 3) . Serum α-tocopherol was positively associated with FN BMD adjusted for all covariates, but only among participants who did not report vitamin E supplement use (β = 0.002; P = 0.04). Associations between serum γ-tocopherol and the α/γ ratio with LS or FN BMD were not observed when covariates were controlled for.
Discussion
In this study of peri-and post-menopausal women, we did not find biologically meaningful changes in bone mineral density or bone resorption and formation markers with dietary intakes or serum concentrations of tocopherols or the α/γ ratio. Supplementation may mask the relationship between tocopherols and BMD, as α-tocopherol was positively associated with FN BMD only among participants who did not report vitamin E supplement use.
The relationships between the vitamin E homologues, bone, and inflammatory markers and states are inconsistent. The inverse relationship between serum α-tocopherol with the inflammatory markers IL-6 and hs-CRP in our study has been observed other studies [30] , including in patients with CVD or its risk factors [31] . Smoking and overweight are inflammatory states with higher levels of oxidative stress [18, 19] , and we observed that individuals with higher BMI and smokers had decreased serum α-tocopherol concentrations, reflecting findings [5, 23, 32] . However, increased α-tocopherol does not appear to be beneficial, as supplementation of 800 IU/day in healthy or overweight adults [33, 34] did not result in a decrease in inflammatory markers and may be due to α-tocopherol acting as a pro-oxidant at high concentrations [11] . The results from γ-tocopherol were opposite to α-tocopherol, as hs-CRP, SAA, E-selectin and BMI were all increased with increasing serum quartiles, similar to other studies. While other studies found γ-tocopherol to be associated with a decrease in inflammation [35] , γ-tocopherol has also been positively associated with BMI [32] and knee osteoarthritis [36] . It is also capable of neutralizing the antioxidant effects of α-tocopherol [17] .
Both tocopherols are also thought to affect bone homeostasis by uncoupling the balance between bone resorption and formation [16, 37] . During the inflammatory response, γ-tocopherol produces nitric oxide (NO) to neutralize RNOS; NO can regulate osteoclasts and has been associated with reduced bone resorption and increased bone formation, although human studies have been inconclusive [37] . Conversely, α-tocopherol uncouples bone turnover resulting in increased resorption through increased osteoclast activity [16] : supplementation with α-tocopherol stimulated osteoclast differentiation without changing osteoblast differentiation. However, these results are not conclusive [38] . These studies HRT hormone replacement therapy, hs-CRP high sensitivity C-reactive protein, IL-6 interleukin-6, SAA serum amyloid A, fDPD/Cr free deoxypyridoline expressed relative to creatinine, fPYD/Cr free pyridinoline expressed relative to creatinine, P1NP N-terminal propeptide of type 1 collagen, national deprivation category 1 indicates most affluent/least deprived.
indicate that the relationships between α-and γ-tocopherol with bone parameters have not been completely elucidated.
The discrepancies between outcomes from animal and human studies may be due to the use of pharmacological doses of vitamin E, rather than one obtainable through diet alone or diet and supplementation. Most mouse studies of vitamin E use 60 mg α-tocopherol/kg body weight in an oral gavage or injection, the latter of which would bypass absorption mechanisms and potentially increase bioavailability of the tocopherol. This animal dose is equivalent to 6 mg/kg body weight in humans [39] , which would result in an intake of 426 mg for a 71-kg human, the mean weight of our participants (equivalent to a biological activity of 635 IU of natural d-α-tocopherol).
Higher vitamin E doses through supplementation studies appear to show no clinical benefit on bone. At 100 mg of α-tocopherol together with 500 mg vitamin C, and combined with aerobic training in a group of healthy elderly participants, there was no effect on bone resorption markers, but a decrease in bone formation markers [39] . Higher doses (600 mg α-tocopherol and 1000 mg/day vitamin C) coupled with resistance training in post-menopausal women prevented LS BMD loss [40] .
The lack of consistent relationships between the tocopherols and LS and FN BMD may also be a result of the lumbar spine containing more trabecular bone compared to the femoral neck. An accelerated loss of trabecular bone following decline in oestrogen during post-menopause could result in trabecular perforation, followed after by bone loss at cortical sites such as the FN [7] . Degenerative diseases in the spine may also incorrectly suggest an increase in BMD due to narrowing of disc space, presence of osteophytes, or end plate sclerosis [41] . We did not have exclusion criteria for degenerative diseases for participants at baseline due to the original study objective of screening for osteoporosis risk fracture, but a sensitivity analysis removing participants who indicated the presence of bone disease did not change our conclusions.
In addition to our study, the studies by Wolf et al. (2005) and Hamidi et al. (2012) were the only two human studies assessing the relationship between tocopherol homologues with bone health. Serum measures were available in only a small (n = 379) subsample of the women from the WHI and did not adjust for women taking supplements in the analysis of serum with BMD, although they reported that supplement users had 272 % higher vitamin E intakes than nonsupplement users. We observed more vitamin E supplement users in the highest quartile of serum α-tocopherol, while we found the reverse for γ-tocopherol, and our regression analyses found some variations when excluding vitamin E supplement users. Vitamin E supplementation depresses γ-tocopherol levels in blood and results may be skewed without accounting for supplementation effects. The α/γ ratio is suggested as a correction method because it would respond to even a slight increase in α-tocopherol from supplementation that would not be markedly noticed in plasma α-tocopherol concentrations [42] . However, our regression analyses did not report any findings.
In the cross-sectional survey of NHANES, the authors similarly found that vitamin E supplement users had significantly higher concentrations of serum α-and lower concentrations of γ-tocopherols [14] . In their regression models, higher serum concentration of γ-tocopherol and a low α/γ ratio were positively associated with the bone formation marker BAP. We found a similar positive association between dietary γ-tocopherol and the bone formation marker P1NP but only in unadjusted models, which could be due to our use of nonfasted samples, as concentrations of P1NP are affected by fDPD/Cr free deoxypyridoline expressed relative to creatinine, fPYD/Cr free pyridinoline expressed relative to creatinine, P1NP N-terminal propeptide of type 1 collagen, CI confidence interval, SE standard error a Energy-adjusted tocopherol residual b Adjusted for age, BMI, physical activity level, smoking status, menopause status and HRT use, alcohol intake, national deprivation category (categories 1-6; 6 as reference) c Natural log-transformed fed and fasting states [43] . While these bone markers provide information for monitoring the dynamic process of bone remodelling, they are subject to influence to time of day, food intake and absence of assay standardization; this variation may not allow an accurate snapshot of actual bone mineralization status or fracture risk [43] . Food sources of tocopherols suggest that γ-tocopherol is a marker of a diet high in refined foods, but we did not find evidence that dietary intakes of tocopherols are correlated with serum concentrations. This is not wholly unexpected given the control of blood tocopherol concentrations by α-TTP, which selectively transports α-tocopherol from the liver into circulation, resulting in α-tocopherol as the predominant form in blood [3, 12] . Wolf et al. (2005) did not report correlations between dietary intake and serum concentrations, but Hamidi et al. (2012) observed total α-tocopherol intake to be positively correlated with serum α-, and negatively correlated with serum γ-tocopherol. They applied a 24-h recall of foods collected prior to blood collection which may be a better indicator for serum levels, as serum tocopherol concentrations rise rapidly after a meal and peaks between 6 and 12 h [29] . However, 24-h recall does not capture habitual intake of foods and intakes of fat would affect serum α-tocopherol concentrations, as higher serum lipid levels result in a longer circulation time for α-tocopherol due to slower lipid catabolism [44] . Our group had previously reported a negative correlation between dietary vitamin E intake and FN BMD change in the early post-menopausal period [45] , which did not take into account the different homologues. These findings did not persist when total intake (diet plus supplements) was considered; one interpretation of the findings was that dietary vitamin E intake was a marker for intake of polyunsaturated fatty acids. We did not detect a similar relationship in the current study, although only BMD and not BMD change was assessed. It may also be that nutrient content of processed foods, such as type of fats used, has changed over time.
Our study's strengths include the use of dietary and serum indicators of vitamin homologue intake, allowing us to assess both the relationship between intakes and physiological concentrations with BMD and assessed the relationship between dietary intakes at two separate visits with separate bone endpoints. Our analyses utilized PCA, eliminating the issue of multicollinearity. We also sought to clarify the role of inflammatory markers as the mechanism between tocopherols and BMD although we did not have sufficient evidence to conclude whether they are contributing factors. Our study included a large number of participants who were selected randomly at baseline from the Community Health Index so that they are more representative of the general population in northeast Scotland.
We acknowledge that our study has several limitations including the use of FFQs and analysing the composition of foods with the food composition database from the USDA rather than the UK's, which contains limited information on the homologues. Use of the USDA food composition database may not accurately reflect the macronutrient and micronutrient content of foods in Scotland. Variations in tocopherol content of foods differ depending on geographical location and practices of farms, and country-specific fortification and preservation practices; it has been argued that the USDA food composition database can be utilized for other countries, particularly for foods such as fruits and vegetables, as they are increasingly imported into the US and may be more likely to reflect a worldwide average [12] . The USDA food composition database does not have γ-tocopherol measures for every food item so levels are likely under-reported. FFQs are used to assess the frequency of foods consumed over a measure of time and lack specificity about foods actually consumed by an individual on one or more days; they may not be sensitive enough to capture serum concentrations of tocopherols. Our population in northeast Scotland had lower dietary intakes of vitamin E compared to the rest of Scotland and UK, although they had adequate intake of >3 mg/day. We observed a shift between visits to a higher intake of both tocopherol homologues from cereals and a lower intake from fats and oils. This may be due to changes in participant's dietary habits as they age or from public health messages on eating less fats and more whole grains. Other limitations include that not all blood samples were taken from an overnight fast (some were 4-h fasts due to an afternoon study visit and some were nonfasted); however, we did not find any values outside the reference range. The use of national deprivation category scores is an indicator of relative deprivation/affluence in a geographical area, rather than individual socioeconomic status, and could therefore misclassify an individual's status. These results are also from two cross-sectional analyses from a cohort of women in northeast Scotland, limiting comparison with other populations. As our population aged, it was possible that healthier women responded to invitations to participate in the study visits; therefore, our results may be biased. We found that non-returners tended to be shorter, heavier and smokers. We hypothesize that attrition may have occurred due to length of the study visit and familial responsibilities such as looking after grandchildren or other relatives.
Conclusion
In this population-based study of older women in northeast Scotland, our overall results did not support an association between dietary intake or serum concentrations of α-and γ-tocopherols with LS or FN BMD. Whether tocopherol homologues have different directions of association with inflammatory biomarkers needs further investigation. Dietary intakes of tocopherol homologues may be an indicator of diet quality and should not be used as proxy for biological availability. Given the marginal associations with BMD, future research may benefit from attention to dietary patterns of intake rather than on individual nutrients.
